Innate and adaptive immunity in human epilepsies

Area of Science:

• Neuroimmunology
• Epileptology

Background:

• Inflammatory mechanisms are increasingly recognized as contributors to seizure and epilepsy development.
• Immune system activation, including innate and adaptive immunity, is implicated in refractory epilepsy.
• Different inflammatory profiles exist in epilepsy patients based on etiology.

Purpose of the Study:

• To explore the role of inflammatory and immune responses in epilepsy.
• To identify potential biomarkers for patient stratification and therapeutic guidance.
• To highlight the importance of developing new immunomodulatory compounds.

Main Methods:

• Review of experimental and clinical evidence on immune mechanisms in epilepsy.
• Analysis of inflammatory responses in various epilepsy types, including autoimmune epilepsies and limbic encephalitis.
• Examination of autoantibodies and peripheral inflammatory markers.

Main Results:

• Innate and adaptive immunity play roles in refractory epilepsy.
• Lymphocyte infiltration is observed in autoimmune epilepsies and certain focal cortical dysplasias.
• Antineuronal autoantibodies are associated with neurologic syndromes, including limbic encephalitis.
• Peripheral inflammatory markers may differentiate between medically controlled and refractory epilepsy.

Conclusions:

• Establishing an autoimmune basis in drug-resistant epilepsy enables targeted immunotherapy.
• Biomarker identification is crucial for selecting patients who benefit from immunomodulatory therapies.
• Further research into novel immunomodulatory compounds is essential due to current therapy limitations.